Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00492505
Title Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors San Diego Pacific Oncology and Hematology Associates
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.